← Back to guidelines
Cardiology518 papers

Inflammatory disease of the central nervous system

Last edited: 4/14/2026

Overview

Inflammatory diseases of the central nervous system (CNS) involve immune-mediated processes that lead to neuroinflammation, affecting neuronal function and survival through complex interactions involving microglia, cytokines, and signaling pathways. 1234

Diagnosis

  • Elevated levels of pro-inflammatory cytokines (IL-1, TNF, IL-6) 2
  • Increased expression of CD40 by microglia and CD40L by astrocytes 2
  • Microglial activation markers such as proliferating cell nuclear antigen and PS receptor expression 4
  • Neurochemical assessments including changes in mitochondrial membrane potential and caspase activity 4
  • Management

  • First-line treatments:
  • - Vitamin B1 (thiamin) supplementation to mitigate neuroinflammation and oxidative stress 2
  • Adjunctive treatments:
  • - Nicorandil for inhibition of inflammasome activation and TLR4 signaling, potentially reducing IL-1β production 3 - Erythropoietin (EPO) to modulate microglial activation and provide neuronal protection 4

    Special Populations

  • Pregnancy: Specific management strategies not detailed in provided abstracts.
  • Pediatrics: Specific management strategies not detailed in provided abstracts.
  • Elderly: Vitamin B1 deficiency may exacerbate neuroinflammation; supplementation may be particularly beneficial 2
  • Comorbidities: Neuroinflammatory conditions may be influenced by underlying immune dysfunction; tailored vitamin B complex support recommended 2
  • Key Recommendations

  • Supplement with Vitamin B1 to reduce neuroinflammation and oxidative stress in patients with CNS inflammatory diseases (Evidence: Moderate) 2
  • Consider the use of nicorandil to inhibit inflammasome activation and TLR4 signaling pathways in managing neuroinflammatory responses (Evidence: Moderate) 3
  • Utilize erythropoietin for its neuroprotective effects through modulation of microglial activity and neuronal protection mechanisms (Evidence: Moderate) 4
  • References

    1 Foley JF. sTREM2 and neuroinflammation. Science signaling 2017. link 2 Spinas E, Saggini A, Kritas SK, Cerulli G, Caraffa A, Antinolfi P et al.. CROSSTALK BETWEEN VITAMIN B AND IMMUNITY. Journal of biological regulators and homeostatic agents 2015. link 3 Zhao AP, Dong YF, Liu W, Gu J, Sun XL. Nicorandil inhibits inflammasome activation and Toll-like receptor-4 signal transduction to protect against oxygen-glucose deprivation-induced inflammation in BV-2 cells. CNS neuroscience & therapeutics 2014. link 4 Chong ZZ, Kang JQ, Maiese K. Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. British journal of pharmacology 2003. link 5 Rothwell NJ. Annual review prize lecture cytokines - killers in the brain?. The Journal of physiology 1999. link

    Original source

    1. [1]
      sTREM2 and neuroinflammation.Foley JF Science signaling (2017)
    2. [2]
      CROSSTALK BETWEEN VITAMIN B AND IMMUNITY.Spinas E, Saggini A, Kritas SK, Cerulli G, Caraffa A, Antinolfi P et al. Journal of biological regulators and homeostatic agents (2015)
    3. [3]
    4. [4]
    5. [5]
      Annual review prize lecture cytokines - killers in the brain?Rothwell NJ The Journal of physiology (1999)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG